Scoring systems for venous thromboembolic disease

Czech version

Authors: J. Hlásenský ¹; Z. Mihalová ^1,2; J. Špinar ^1,2; O. Ludka ^1,2
Authors‘ workplace: Interní kardiologická klinika LF MU a FN Brno ¹; Mezinárodní centrum klinického výzkumu, FN u sv. Anny v Brně ²
Published in: Kardiol Rev Int Med 2015, 17(2): 126-130
Category: Cardiology Review

Overview

Deep venous thrombosis and pulmonary embolism are severe clinical manifestations of venous thromboembolic disease affecting more than 1.5 million Europeans each year; one third of these patients die. The most disturbing fact is that 90% of these patients suffer from sudden embolism with no proven pre-existing source of pulmonary embolism. This is the main reason supporting the development of preventive, diagnostic and therapeutic methods for venous thromboembolic disease, including score systems and clinical algorithms for various groups of patients.

Keywords:
thromboembolic disease – deep venous thrombosis – pulmonary embolism – Padua prediction score – Caprini score – Wells Score – Wicki score – Geneva score – Kline algorithm – PESI – sPESI

Sources

1. Widimský J, Malý J, Eliáš P et al. Doporučení diagnostiky, léčby a prevence plicní embolie, verze 2007. [online] Dostupné z: http:/ / www.kardio‑ cz.cz/ resources/ upload/ data/ 128_22- plicni_embolie2008.pdf.

2. Widimský J, Malý J et al. Akutní plicní embolie a žilní trombóza. 3. vyd. Praha: Triton 2011.

3. Hirmerová J, Karetová D, Malý R et al. Doporučený postup České angiologické společnosti ČLS JEP. Akutní žilní trombóza 2014: Současný stav prevence, diagnostiky a léčby. [online] Dostupné z: http:/ / www.angiology.cz/ Angiology/ media/ content/ Zilni_tromboza_doporuceni.pdf.

4. Wells PS, Hirsh J, Anderson DR et al. Accuracy of clinical assessment of deep‑ vein thrombosis. Lancet 1995; 345: 1326– 1330.

5. Rogers MA, Levine DA, Blumberg N et al. Triggers of hospitalization for venous thromboembolism. Circulation 2012; 125: 2092– 2099. doi: 10.1161/ CIRCULATIONAHA.111.084467.

6. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51: 70– 78.

7. Riedel M, Stanek V, Widimsky J et al. Long‑term follow‑up of patiens with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respirátory data. Chest 1982; 81: 151– 158.

8. Prevention and treatment of venous thromboembolism. International Consensus Statement. Int Angiol 2013; 3: 111– 260.

9. Malý J, Kessler P, Gumulec P et al. Trendy v profylaxi žilní tromboembolické nemoci. 2. vyd. Praha: Mladá fronta 2013.

10. Palareti G, Schellong S. Isolated distal deep vein thrombosis: chat we know and chat we are doing. J Thromb Haemost 2012; 10: 11– 19. doi: 10.1111/ j.1538‑ 7836.2011.04564.x.

11. O'Sullivan GJ, Semba CP, Bittner CA et al. Endovascular management of iliac vein compression (May‑ Thurner) syndrome. J Vasc Interv Radiol 2000; 11: 823– 836.

12. Ocak G, Vossen CY, Verduijn M et al. Risk of venous thrombosis in patiens with major illnesses: results from the MEGA study. J Thromb Haemost 2013; 11: 116– 123. doi: 10.1111/ jth.12043.

13. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 92. [online] Available from: https:/ / www.nice.org.uk/ guidance/ cg92.

14. Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev 2007; CD003076.

15. Nicolaides AN, Fareed J, Kakkar AK et al. Prevention and treatment of venous thromboembolism. International Consensus Statement. Int Angiol 2013; 32: 111– 260.

16. Eklof B, Perrin M, Delis KT et al. Updated terminology of chronic velus disorders: The VEIN-TERM transatlantik interdisciplinary konsensus document. J Vasc Surg 2009; 49: 498– 501. doi: 10.1016/ j.jvs.2008.09.014.

17. Casey ET, Murad MH, Zumaeta‑Garcia M et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg 2012; 55: 1463– 1473. doi: 10.1016/ j.jvs.2011.12.082.